Skip to content

Effects of Photobiomodulation and Ozone Therapy on pain and functionality in knee osteoarthritis

Comparative analysis of the effects of Photobiomodulation and Ozone therapy on pain and functionality of individuals with knee osteoarthritis: Controlled and Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9c4jnv4
Enrollment
Unknown
Registered
2023-07-12
Start date
2023-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gonarthrosis [arthrosis of knee]

Interventions

This is a controlled, randomized, blind clinical trial with a quantitative approach. 60 volunteers divided into 3 arms will be selected: Group 1: Control group: volunteers will undergo a standard reha
Group 2: Photobiomodulation Group: volunteers will undergo rehabilitation and laser therapy applications. Irradiation will be performed using the punctual technique, in 5 points (medial and lateral re
Group 3: Ozone therapy group: volunteers will undergo rehabilitation and ozone therapy applications. The application of ozone will be performed at 5 points (medial and lateral region) of the affected
E02.594.540

Sponsors

Universidade Brasil
Lead Sponsor
Universidade Brasil
Collaborator

Eligibility

Sex/Gender
Female
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: diagnosis of knee osteoarthritis (KOA) grades II and III confirmed by radiological examination according to the American College of Rheumatology - Kellgren-Lawrence criteria (Link et al., 2013); women; age between 50 and 70 years; body mass index (BMI) between 22 and 30 kg/m²; classified as little active and irregularly active according to criteria established by the International Physical Activity Questionnaire – short version (IPAQ); availability to participate in the treatment plan; clinical signs such as pain and joint stiffness in at least one of the compartments of the knee joint (medial or lateral tibiofemoral and patellofemoral joint)

Exclusion criteria

Exclusion criteria: medical restrictions that make it impossible to participate in the study evaluations (cardio-respiratory, rheumatic, neurological and vestibular alterations); systemic arthritis; body mass index greater than 30 kg/m2; symptomatic hip osteoarthritis (OA); use of conventional, unconventional or alternative treatments that could potentially have an effect on the study results (physiotherapy and/or intra-articular corticosteroid or hyaluronic acid injections during the last 3 months)

Design outcomes

Primary

MeasureTime frame
Decreased pain, verified by the improvement of 3 points in the Numerical Scale of Pain colllected inicial and end of study.

Secondary

MeasureTime frame
Improved quality of life measured by the Knee Injury and Osteoarthritis Outcome Score (KOOS) after treatment;Improved functionality assessed using the Lequesne Questionnaire;Improved mobility and balance assessed by the Timed Get Up and Go (TGUG).;Improvement in lower limb performance assessed using the Short Physical Performance Battery (SPPB);Improvement in functional exercise capacity assessed by the six-minute walk test (6MWT).;improvement in range of motion assessed by biophotogrammetry

Countries

Brazil

Contacts

Public ContactThiago Rezzo

Universidade Brasil

thiagorezzo@gmail.com+55(11)2070-0167

Outcome results

None listed

Source: REBEC (via WHO ICTRP)